When TMZ was added to the tumor cells there was an up-regulation of CD44, CD54 and MHC I expression in NK supernatant-treated GS025 and NCH421k cells as compared to only NK supernatant- and only TMZ-treated cells. Here, CD44 is linked to neoplasm.